DrugPipeline.net

Uveitis - Epidemiology Forecast to 2023; New Report Launched

LogoUveitis - Epidemiology Forecast To 2023" provides an overview of the epidemiology trends of Uveitis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Uveitis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Uveitis. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Thyroid Cancer - Epidemiology Forecast to 2023; New Report Launched

Logo"Thyroid Cancer - Epidemiology Forecast To 2023" provides an overview of the epidemiology trends of Thyroid Cancer in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Thyroid Cancer prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Thyroid Cancer. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Chronic Heart Failure - Epidemiology Forecast to 2023; New Report Launched

Logo"Chronic Heart Failure - Epidemiology Forecast To 2023" provides an overview of the epidemiology trends of Chronic Heart Failure in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Chronic Heart Failure prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Chronic Heart Failure. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Global Immunohematology Market 2016-2020; New Report Launched

LogoBlood loss or anemia can lead to chronic health problems; therefore, clinicians performs blood transfusion that can help to get relief from chronic health problems. To transfuse, blood clinicians or hospitals take blood units present in their own integrated blood banks or from other centers. Immunohematology, also commonly known as blood banking, helps to screen the donor blood components for blood antigens, Rh factor, plasma, and white blood cell components. It helps to reduce blood transfusion-related diseases such as HIV and thalassemia. According to the guidelines by World Health Organization (WHO), donated blood is screened before it is transfused to protect the people from such fatalities in most of the countries.

Global Heart Rate Monitoring Devices Market 2016-2020; New Report Launched

LogoDiagnostic wearable medical devices, used for monitoring, controlling, and tracking an individual's vital signs at regular intervals, have gained momentum in the past few years. These devices measure physiological information through remote or wireless communication and transmit this information to medical professionals or the user. These autonomous, non-invasive devices help assess specific medical functions such as body temperature, blood pressure, glucose quantity, respiratory rate, heart rate, and blood oxygen saturation.

Global Genome Engineering Market 2016-2020; New Report Launched

LogoGenetic engineering is an advanced technology that modifies chromosomal DNA of animals and plants using molecular scissors (such as restriction enzyme that cut DNA into pieces). Genome engineering is now in the forefront of healthcare gaining traction with its use to fight diseases such as cancer, HIV, Malaria, sickle cell diseases.

Global Fluoroscopy C-Arms Market 2016-2020; New Report Launched

LogoA mobile C-arm is a form of specialized diagnostic equipment that employs overhead X-ray image intensifiers, which aid in the visualization of the anatomical structure using fluoroscopic dyes. It offers safe screening as it is a non-invasive device and allows for rapid diagnosis and treatment. The development of the C-arms increases the emphasis on MIS, leading to reduced hospital stay. Therefore, there will be an increase in sales of C-arm equipment components in the hospital sector during the forecast period. The growing number of ambulatory surgical centres that perform numerous procedures is expected to further increase the demand for mobile C-arms in the market during the forecast period.

Global DNA Microarray Market 2016-2020; New Report Launched

LogoA DNA microarray is a collection of microscopic DNA spots that are attached to a solid surface. DNA microarrays allow the simultaneous monitoring of expression of thousands of genes. They can be used for both determination of mRNA levels and for genotyping. Protein microarrays help in monitoring the level of translation of proteins and the testing of enzyme actions. The tool is widely used to ascertain whether a particular individual's DNA contains a mutation in genes.

Global Age-Related Macular Degeneration Market 2016-2020; New Report Launched

LogoAMD is the degeneration or disintegration of the eye's macula. The macula is a small area of the retina that is responsible for the central vision. AMD can be classified into two types: dry and wet macular degenerations. When the tiny abnormal blood vessels begin growing toward the macula, it develops into wet AMD. Dry AMD occurs when small, yellowish deposits called drusen start accumulating beneath the macula. While some treatments are available for wet AMD; there is no treatment available at the moment for dry AMD.

Non - Epidemiology Forecast to 2023; New Report Launched

Logo"Non - Epidemiology Forecast To 2023" provides an overview of the epidemiology trends of Non in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Non prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Non. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.